Global health campaigns emphasize early breast and prostate cancer detection

Global health organizations and medical institutions are intensifying efforts for breast and prostate cancer awareness during the Pink October and Blue November campaigns. The World Health Organization estimates that 2.4 million women were diagnosed with breast cancer in 2024, emphasizing that early detection through regular screening is critical for improving survival rates.

Medical experts are highlighting specific diagnostic challenges and warning signs. In Brazil, clinicians are urging patients to watch for cutaneous indicators such as skin dimpling, nipple retraction, or redness. In the United States, research indicates that women with dense breast tissue may require more advanced imaging, as standard mammograms can sometimes miss cancer cells that appear white on scans. Additionally, there is a noted rise in breast cancer diagnoses among women under the age of 45.

In South Africa, the Breast Imaging Society of South Africa (BISSA) is working to combat fears and misinformation, noting that a diagnosis does not always necessitate radical treatments like chemotherapy or mastectomy due to advances in tailored, breast-conserving surgeries. Meanwhile, institutions like CERN are hosting local awareness stands to provide interactive education and answer community questions regarding prevention and risk factors.